CY1106693T1 - Πελετες οι οποιες περιεχουν υδροχλωρικη βενλαφαξινη - Google Patents
Πελετες οι οποιες περιεχουν υδροχλωρικη βενλαφαξινηInfo
- Publication number
- CY1106693T1 CY1106693T1 CY20071100874T CY071100874T CY1106693T1 CY 1106693 T1 CY1106693 T1 CY 1106693T1 CY 20071100874 T CY20071100874 T CY 20071100874T CY 071100874 T CY071100874 T CY 071100874T CY 1106693 T1 CY1106693 T1 CY 1106693T1
- Authority
- CY
- Cyprus
- Prior art keywords
- pellets
- pellets containing
- weight
- hydrochloride
- venlafaxine hydrochloride
- Prior art date
Links
- 239000008188 pellet Substances 0.000 title abstract 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
- PNVNVHUZROJLTJ-UHFFFAOYSA-N venlafaxine Chemical compound C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 PNVNVHUZROJLTJ-UHFFFAOYSA-N 0.000 title 1
- 229960004688 venlafaxine Drugs 0.000 title 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract 2
- 229960002416 venlafaxine hydrochloride Drugs 0.000 abstract 2
- QYRYFNHXARDNFZ-UHFFFAOYSA-N venlafaxine hydrochloride Chemical compound [H+].[Cl-].C1=CC(OC)=CC=C1C(CN(C)C)C1(O)CCCCC1 QYRYFNHXARDNFZ-UHFFFAOYSA-N 0.000 abstract 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 abstract 1
- 239000008108 microcrystalline cellulose Substances 0.000 abstract 1
- 229940016286 microcrystalline cellulose Drugs 0.000 abstract 1
- 238000005453 pelletization Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000001103 potassium chloride Substances 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000011780 sodium chloride Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Η εφεύρεση σχετίζεται με πελέτες οι οποίες περιέχουν υδροχλωρική βενλαφαξίνη και μια διαδικασία για την παρασκευή αυτών. Οι πελέτες σύμφωνα με την εφεύρεση είναι σχεδόν σφαιρικές στο σχήμα και περιλαμβάνουν φαρμακευτικώς δραστική υδροχλωρική βενλαφαξίνη σε μια ποσότητα το πολύ 80% κατά βάρος, επιπλέον 10 έως 60% κατά βάρος χλωριούχο νάτριο και/ή χλωριούχο κάλιο, 10 έως 60% κατά βάρος μικροκρυσταλλική κυτταρίνη και κατ' επιλογή άλλα φαρμακευτικώς αποδεκτά έκδοχα και/ή πρόσθετα τα οποία προάγουν την πελετοποίηση. Οι εν λόγω πελέτες είναι ιδιαίτερα κατάλληλες για επικάλυψη με ένα στρώμα το οποίο εξασφαλίζει μια ελεγχόμενη αποδέσμευση του δραστικού συστατικού.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0303382A HUP0303382A2 (hu) | 2003-10-10 | 2003-10-10 | Venlafaxin-hidroklorid-tartalmú pelletek |
PCT/HU2004/000095 WO2005034930A1 (en) | 2003-10-10 | 2004-10-08 | Pellets containing venlafaxine hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1106693T1 true CY1106693T1 (el) | 2012-05-23 |
Family
ID=90001704
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20071100874T CY1106693T1 (el) | 2003-10-10 | 2007-07-02 | Πελετες οι οποιες περιεχουν υδροχλωρικη βενλαφαξινη |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1677777B1 (el) |
CN (1) | CN1882321B (el) |
AT (1) | ATE359771T1 (el) |
AU (1) | AU2004280132B2 (el) |
BG (1) | BG109539A (el) |
CY (1) | CY1106693T1 (el) |
CZ (1) | CZ2006269A3 (el) |
DE (1) | DE602004006009T2 (el) |
DK (1) | DK1677777T3 (el) |
EA (1) | EA009695B1 (el) |
ES (1) | ES2285538T3 (el) |
HK (1) | HK1098364A1 (el) |
HR (2) | HRP20060136A2 (el) |
HU (1) | HUP0303382A2 (el) |
IL (1) | IL174830A (el) |
NO (1) | NO20062082L (el) |
PL (2) | PL1677777T3 (el) |
PT (1) | PT1677777E (el) |
RS (2) | RS52150B (el) |
SI (1) | SI1677777T1 (el) |
SK (1) | SK50442006A3 (el) |
UA (1) | UA82268C2 (el) |
WO (1) | WO2005034930A1 (el) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02004293A (es) | 1999-10-29 | 2002-10-31 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada.. |
US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
CN100518827C (zh) | 2000-10-30 | 2009-07-29 | 欧罗赛铁克股份有限公司 | 控释氢可酮制剂 |
IL146462A (en) | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
US20080193524A1 (en) * | 2005-07-28 | 2008-08-14 | Dr. Reddy's Laboratories Ltd. | Extended Release Venlafaxine Compositions |
WO2007135470A1 (en) * | 2006-05-19 | 2007-11-29 | EGIS GYÓGYSZERGYÁR Nyilvánosan Müködö Részvénytársaság | Process for the preparation and surface coating of pellets |
US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
US8927025B2 (en) | 2010-05-11 | 2015-01-06 | Cima Labs Inc. | Alcohol-resistant metoprolol-containing extended-release oral dosage forms |
EP2579857A1 (en) * | 2010-05-11 | 2013-04-17 | Cima Labs Inc. | Alcohol-resistant extended release dosage forms comprising venlafaxine |
EP2934487A1 (en) * | 2012-12-19 | 2015-10-28 | ratiopharm GmbH | Film coated pellets |
CN103893151B (zh) * | 2012-12-31 | 2018-04-27 | 石药集团中奇制药技术(石家庄)有限公司 | 一种盐酸文拉法辛缓释胶囊及其制备方法 |
WO2015065547A1 (en) | 2013-10-31 | 2015-05-07 | Cima Labs Inc. | Immediate release abuse-deterrent granulated dosage forms |
WO2020225773A1 (en) | 2019-05-07 | 2020-11-12 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
US20220062200A1 (en) | 2019-05-07 | 2022-03-03 | Clexio Biosciences Ltd. | Abuse-deterrent dosage forms containing esketamine |
CN114028577A (zh) * | 2021-10-20 | 2022-02-11 | 珠海市东辰制药有限公司 | 一种二氧化硅丸芯及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1331003B1 (en) * | 1996-03-25 | 2015-08-26 | Wyeth LLC | Extended release formulation containing venlafaxine |
PE57198A1 (es) * | 1996-03-25 | 1998-10-10 | American Home Prod | Formula de liberacion prolongada |
UA77145C2 (en) * | 1997-11-05 | 2006-11-15 | Wyeth Corp | Extended release dosage formulation |
CN1334080A (zh) * | 2001-07-25 | 2002-02-06 | 成都康弘制药有限公司 | 盐酸万拉法新缓释片及其制备方法 |
IL146462A (en) * | 2001-11-13 | 2015-02-26 | Lycored Bio Ltd | Prolonged-release preparations containing as an active compound and analapaxin hydrochloride |
US20030190351A1 (en) * | 2002-03-28 | 2003-10-09 | Synthon Bv | Extended release venlafaxine formulations |
-
2003
- 2003-10-10 HU HU0303382A patent/HUP0303382A2/hu unknown
-
2004
- 2004-08-10 UA UAA200605099A patent/UA82268C2/uk unknown
- 2004-10-08 DK DK04791654T patent/DK1677777T3/da active
- 2004-10-08 DE DE602004006009T patent/DE602004006009T2/de active Active
- 2004-10-08 RS RS20060252A patent/RS52150B/en unknown
- 2004-10-08 EA EA200600675A patent/EA009695B1/ru not_active IP Right Cessation
- 2004-10-08 WO PCT/HU2004/000095 patent/WO2005034930A1/en active IP Right Grant
- 2004-10-08 CN CN2004800330326A patent/CN1882321B/zh not_active Expired - Fee Related
- 2004-10-08 ES ES04791654T patent/ES2285538T3/es active Active
- 2004-10-08 PL PL04791654T patent/PL1677777T3/pl unknown
- 2004-10-08 AU AU2004280132A patent/AU2004280132B2/en not_active Ceased
- 2004-10-08 CZ CZ20060269A patent/CZ2006269A3/cs unknown
- 2004-10-08 EP EP04791654A patent/EP1677777B1/en active Active
- 2004-10-08 SK SK5044-2006A patent/SK50442006A3/sk unknown
- 2004-10-08 SI SI200430364T patent/SI1677777T1/sl unknown
- 2004-10-08 AT AT04791654T patent/ATE359771T1/de active
- 2004-10-08 PT PT04791654T patent/PT1677777E/pt unknown
- 2004-10-08 RS YUP-2006/0252A patent/RS20060252A/sr unknown
- 2004-10-08 PL PL379541A patent/PL379541A1/pl not_active IP Right Cessation
-
2006
- 2006-04-06 IL IL174830A patent/IL174830A/en not_active IP Right Cessation
- 2006-04-07 HR HR20060136A patent/HRP20060136A2/xx not_active Application Discontinuation
- 2006-05-09 NO NO20062082A patent/NO20062082L/no unknown
- 2006-05-10 BG BG109539A patent/BG109539A/bg unknown
-
2007
- 2007-05-04 HK HK07104778.3A patent/HK1098364A1/xx not_active IP Right Cessation
- 2007-07-02 CY CY20071100874T patent/CY1106693T1/el unknown
- 2007-07-16 HR HR20070322T patent/HRP20070322T3/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1677777A1 (en) | 2006-07-12 |
DE602004006009T2 (de) | 2008-01-10 |
WO2005034930A1 (en) | 2005-04-21 |
PL1677777T3 (pl) | 2007-08-31 |
EA009695B1 (ru) | 2008-02-28 |
CZ2006269A3 (cs) | 2006-07-12 |
HRP20070322T3 (en) | 2007-09-30 |
HK1098364A1 (en) | 2007-07-20 |
HRP20060136A2 (en) | 2006-06-30 |
PL379541A1 (pl) | 2006-10-02 |
DE602004006009D1 (de) | 2007-05-31 |
HUP0303382A2 (hu) | 2005-08-29 |
UA82268C2 (uk) | 2008-03-25 |
IL174830A0 (en) | 2008-04-13 |
IL174830A (en) | 2010-04-15 |
BG109539A (bg) | 2006-11-30 |
EP1677777B1 (en) | 2007-04-18 |
SK50442006A3 (sk) | 2006-08-03 |
RS20060252A (en) | 2008-08-07 |
PT1677777E (pt) | 2007-06-21 |
AU2004280132A1 (en) | 2005-04-21 |
NO20062082L (no) | 2006-05-09 |
RS52150B (en) | 2012-08-31 |
ATE359771T1 (de) | 2007-05-15 |
CN1882321B (zh) | 2011-06-08 |
ES2285538T3 (es) | 2007-11-16 |
AU2004280132B2 (en) | 2009-10-22 |
SI1677777T1 (sl) | 2007-10-31 |
CN1882321A (zh) | 2006-12-20 |
EA200600675A1 (ru) | 2006-08-25 |
DK1677777T3 (da) | 2007-09-03 |
HUP0303382D0 (en) | 2003-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1106693T1 (el) | Πελετες οι οποιες περιεχουν υδροχλωρικη βενλαφαξινη | |
CY1118191T1 (el) | Αναλογα δεοξυνοζιριμυκινης και οι χρησεις τους ως αναστολεις γλυκοζυλοκεραμιδασης | |
CY1126116T1 (el) | Φαρμακευτικες συνθεσεις αποτελουμενες απο νιλοτινιμπη | |
NO20073959L (no) | Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller | |
CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
RS51213B (sr) | Farmaceutski vaginalni gel koji sadrži tenofovir | |
CY1117995T1 (el) | Δευτεριωμενα παραγωγα κατεχολαμινης και φαρμακα που περιεχουν τις εν λογω ενωσεις | |
CY1117470T1 (el) | Στερεα δοσολογικα σκευασματα με βελτιωμενη ενδοστοματικη προσροφηση | |
CY1107298T1 (el) | Υδατοδιαλυτα κοκκια μελοξικαμης | |
CR8102A (es) | Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa | |
CY1111934T1 (el) | Σταθεροποιημενες φαρμακευτικες συνθεσεις οι οποιες περιεχουν φεσοτεροδινη | |
CY1112499T1 (el) | Φαρμακευτικες συνθεσεις ενος νευροδραστικου στεροειδους και χρησεις αυτων | |
CY1106996T1 (el) | Δισκιο με υψηλο φορτιο φαρμακου | |
CY1117584T1 (el) | Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, cx3cr1 | |
CY1118180T1 (el) | Μεθοδος για παρασκευη στερεας φαρμακευτικης συνθεσης | |
CY1111275T1 (el) | Κρυσταλλικη μορφη μιας ενωσης κινολινονης-καρβοξαμιδιου | |
CY1113003T1 (el) | Ευσταθη παρασκευασματα laquinimod | |
NO20085099L (no) | Puritonderivativer som HM74A agonister | |
CY1106741T1 (el) | Επικαλυμμενα μινι-δισκια παρατεταμενης αποδεσμευσης υδροχλωρικης βενλαφαξινης | |
CY1106148T1 (el) | Φαρμακευτικη συνθεση πepιλαμβανουσα ν-((1-κ-βουτυλ-4-πιπepιδινυλ) μεθυλ)-3,4-διϋδρο-2η-(1,3) οξαζινο (3,2-α) ινδολο-10-καρβοξαμιδιο ή αλας και μεθοδος για παρασκευη αυτης που πepιλαμβανει ξηρη κοκκοποιηση | |
CY1113482T1 (el) | Αναστολεις υποδοχεα σιγμα | |
CY1112911T1 (el) | Θεραπευτικος παραγοντας ηπατικης νοσου, που περιεχει παραγωγο 2-αμινο-1,3-προπανοδιολης ως δραστικο συστατικο | |
CY1113504T1 (el) | Παραγωγο προπανο-1,3-διονης ή αλας αυτου | |
BRPI0817275A2 (pt) | Combinação farmacêutica de alisquireno e valsartana | |
CY1118583T1 (el) | Σταθερες δοσολογικες μορφες ανθελονοσιακων σπιρο και δισπιρο 1,2,4-τριοξολανιων |